Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Metabolic Bone Disease
General Topic: Clinical Science

28T32: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (2591–2596)

Tuesday, October 28, 2025
1:00 PM - 2:30 PM Central Time
Location: W192A-C
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • CT

    Carter Thorne, MD, FRCPC, FACP, FACR, MACR

    Southlake Regional Health Centre
    Newmarket, Ontario, Canada

    Disclosure(s): Jamp: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Medexus: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sandoz: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • SK

    Sonali Khandelwal, MD

    Associate Professor
    Rush University Medical Center
    Chicago, Illinois, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 1:00 PM - 1:15 PM Central Time
    Association Between Changes in Bone Quality Parameters and Inflammatory Ratios in Postmenopausal Women Treated with Romosozumab: A Retrospective Observational Study

    Presenting Author: Montserrat Robustillo Villarino, MD, PhD, MSc (she/her/hers) – Conselleria de Sanitat Valenciana

  • 1:15 PM - 1:30 PM Central Time
    Romosozumab and Denosumab Combination Therapy in Postmenopausal Osteoporosis

    Presenting Author: Giovanni Adami, MD – University of Verona, Italy

  • 1:30 PM - 1:45 PM Central Time
    Single Switch from Reference Denosumab to TVB-009 in Women with Postmenopausal Osteoporosis: Analysis of the Phase 3, Randomized, Double-Blind, Multinational, Multicenter Study

    Presenting Author: Anton Buchner, PhD – Teva Pharmaceuticals

  • 1:45 PM - 2:00 PM Central Time
    Comparing Immunogenicity Between TVB-009 and Reference Denosumab in Healthy Adults and Participants with Postmenopausal Osteoporosis

    Presenting Author: Bracha Timan, PhD, MBA – Teva Pharmaceuticals Ind Ltd

  • 2:00 PM - 2:15 PM Central Time
    Impact of Different Types of Physical Activity on Bone Health in Patients with Inflammatory Rheumatic Diseases: a Cross-Sectional Analysis from a Prospective Cohort Study

    Presenting Author: Edgar Wiebe, MD – Charité University Medicine Berlin

  • 2:15 PM - 2:30 PM Central Time
    Predicting Osteoporosis Using Routine Clinical Data: A Machine Learning Approach

    Presenting Author: Shiza Sarfraz, MD – Brody School of Medicine